Spoligotypes of CzechPopulations of Mycobacterium tuberculosis
Authors:
M. Kubín; J. Driscoll; V. Polanecký; B. Kozáková; J. Zdražílek; L. Mezenský
Authors‘ workplace:
Hygienická stanice hlavního města Prahy, Wadsworth Center, New York State Department of Health, Albany, New York Krajská hygienická stanice, Brno
Published in:
Epidemiol. Mikrobiol. Imunol. , 2002, č. 2, s. 52-59
Category:
Overview
In the introduction the authors describe molecular genetic principles of spacer oligonucleotide typing of the M. tuberculosis complex and mention in detail the methodical procedure of implementation of this examination technique incl, computer analysis of results. In the pilot part of the study the authors describe examination of 71 strains of M. tuberculosis isolated from patients living in the capital of Prague and 37 strains from patients in the South Moravian region of the Czech Republic. In the group of Prague strains a total of 7 clusters was identified formed by 2 -14 identical profiles of spoligotypes and 37 individually different profiles. In the South Moravian strains there were 6 clusters with 2 - 14 identical spoligotypes and 10 non-clustered profiles. In neither of the groups there were spoligotypes typical for the genetic family Beijing or Afrika. The study is a preliminary molecular epidemiologcckl analysis where DNA fingerprint RFLP profiles are compared with spoligotypes of strains of M. tuberculosis of patients from the capital of Prague and the South Moravian region of the Czech Republic.
Key words:
Mycobacterium tuberculosis - spoligotyping.
Labels
Hygiene and epidemiology Medical virology Clinical microbiologyArticle was published in
Epidemiology, Microbiology, Immunology
2002 Issue 2
Most read in this issue
- Evaluation of the Effectiveness of an Automatic Cultivation System for Detection of Mycobacteria BACTEC MGIT 960 as Compared with the Classical Cultivation Method
- Lyme Borreliosis - Incidence of Antimyelin Antibodies in Serum
- The Risk of Fungal Contamination of Food Distributed in Hospitals for Immunocompromised Patients
- Serological Evidence of Hantaviral Antibodies